Lown Institute Study Finds Unnecessary Back Surgeries Cost Medicare $600 Million Annually

December 10, 2024

EGWP Medicare

A new analysis from the Lown Institute, an independent think tank, found that hospitals performed more than 200,000 unnecessary back surgeries on Medicare beneficiaries in the U.S. over three years. Roughly $2 billion was spent on the “low value” procedures while patients were put at risk of poor outcomes, researchers wrote.

The researchers looked at claims for common back surgeries, including spinal fusion, laminectomy, and vertebroplasty, over a three-year period for Medicare fee-for-service (2020-2022) and MA (2019-2021). Roughly 14% of spinal fusions and laminectomies met criteria for overuse, meaning patients with low back pain did not have certain diagnoses, such as trauma, a herniated disc, or scoliosis, and 11% of patient visits for osteoporotic fracture resulted in an unnecessary vertebroplasty.

Overuse rates varied greatly – from less than 1% to more than 50% – between hospitals, with New Hampshire, Iowa, Massachusetts, and Pennsylvania having the highest overuse rates of spinal fusion/laminectomy. Vikas Saini, president of the Lown Institute, said the variability is frustrating in its persistence, with data showing that the vast majority of vertebroplasties don’t work but it seems many doctors “still haven’t gotten the memo.”

Initiatives

Calls grow for Drug Patent reform

In a recent blog post, the Pharmaceutical Care Management Association (PCMA) highlighted increased attention to pharmaceutical companies’ abuse of drug patents. Last month, the Supreme Court unanimously ruled in favor of a generic drugmaker in a “skinny labeling” case, a victory for patients. Skinny labels allow generic and biosimilar competitors to launch products for non-patented indications, helping accelerate […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

perspectives

AHIP calls for Bipartisan reform to address health care cost drivers

On July 23, AHIP President and CEO Mike Tuffin wrote an opinion piece in The New York Times saying, “common-sense bipartisan reforms are needed to promote competition in care delivery and prescription drugs, protect consumers from providers and drugmakers’ anticompetitive practices and transition away from the perverse incentives of fee-for-service medicine.” Tuffin notes that health […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

Solutions

PCMA urges preserving patient access and flexibility in new fertility benefits rule

PCMA recently submitted comments to HHS, DOL, and the Treasury (the Departments) in response to the proposed rule establishing a new category of limited excepted benefits for fertility services. PCMA supports the Departments’ goal of expanding access to fertility care while encouraging employer innovation but urged several targeted refinements to ensure the framework is operationally […]
read more >

August 11, 2026

marketplace medicaid

You may also like